Abstract
PICO question Does administration of the selective serotonin reuptake inhibitor (SSRI) fluoxetine reduce the severity and / or frequency of some anxiety related behaviours in companion dogs, of at least 8 months of age, when compared with no pharmacological treatment? Clinical bottom line Category of research question Treatment The number and type of study designs reviewed Two studies, both randomised, were critically appraised. Each had a placebo control group and the dog's owners were blinded to the treatments Strength of evidence Moderate Outcomes reported Both studies provide moderate evidence that fluoxetine, when dispensed at 1-2 mg/kg per day by oral administration and not involving a behavioural modification program for the patient, may reduce some behaviours associated with separation anxiety and / or compulsive disorders. Both studies indicate that a reduction in some unwanted behaviours may be observed after 1 week of fluoxetine medication. Both studies recommend that behavioural and environmental modifications are important adjuncts to pharmacologic treatment of dogs with either compulsive disorders or separation anxiety. Both studies also report that some dogs treated with fluoxetine experienced anorexia / decreased appetite and lethargy, although most of these effects were transient Conclusion The clinical recommendation is that fluoxetine at 1-2 mg/kg administered orally, once daily, may be beneficial in reducing the severity of some canine anxiety related behaviours.